Tel.: +34 91 736 2385
LOCAL TIME
Contact: Katarina Gluic
Hours: Mon-Thu 8:30-17:00 Fri 8:30-15:00
01:37
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments

13th International Conference on Malignant Lymphoma

 

17-20 June 2015 Lugano
FAQs
   
Discussion forum - 13th International Conference on Malignant Lymphoma
    Topic - Indolent lymphoma

If you are already registered in PosterSessionOnline, enter your e-mail and click on LOGIN. Otherwise click on REGISTER
  
 Thread / Poster  Author  Replies  Last reply
Follicular lymphoma and clinical characteristics of histologic transformation  Míriam Méndez García 1      6/8/2015 10:01:00 PM  
Rituximab Maintenance (MR) improves PFS and OS in all Patients (pts) with Follicular Lymphoma (FL) - Individual Patient Data (IPD) meta-analysis  Liat Vidal 1      6/8/2015 9:20:00 PM  
T-cell subpopulations quantified by flow cytometry in lymph node cell suspensions identify a group of patients with follicular lymphoma with favorable outcome  Laura Magnano Mayer 1      6/8/2015 7:42:00 PM  
Targeting Mutated BRAF with Vemurafenib is Safe and Highly Active in Relapsed/Refractory Hairy Cell Leukemia: a Phase-2 Italian Clinical Trial (HCL-PG01)  Enrico Tiacci 1      6/8/2015 7:26:00 PM  
The clinical course of patients with follicular lymphoma in the rituximab era  inas el-najjar 1      6/8/2015 3:28:00 PM  
Extended Dosing Lenalidomide with Intensified Rituximab in Untreated Indolent NHL  Nathan Fowler 1      6/8/2015 5:50:00 AM  
Event-free Survival at 12 Months and Subsequent Overall Survival in Patients with Follicular Lymphoma Managed in the Rituximab Era  Emmanuel Bachy 1      6/7/2015 11:01:00 PM  
Higher risk of rituximab intolerance in patients with Waldenstrom Macroglobulinemia  Jorge Castillo 1      6/1/2015 6:56:00 PM  
Comparison of lenalidomide and rituximab with chemoimmunotherapy in patients with untreated grade 1-2 follicular lymphoma treated at the MD Anderson Cancer Center  Chan Yoon Cheah 1      5/29/2015 6:10:00 PM  
       




Most viewed poster for this congress
Poster: 9
Visits: 649
Title: Ibrutinib in combination with Rituximab for Relapsed Mantle Cell Lymphoma: An Update from a Phase II Clinical Trial
Authors: Michael Wang ,
Centre: The University of Texas MD Anderson Cancer Center

Poster most viewed in this topic
Poster: 192
Visits: 298
Title: Extended Dosing Lenalidomide with Intensified Rituximab in Untreated Indolent NHL
Authors: Nathan Fowler , Chan Yoon Cheah, Sattva Neelapu, Loretta Nastoupil, Francesco Turturro, Fredrick Hagemeister, Larry W. Kwak, Jorge Romaguera, Michelle Fanale, Luis Fayad, Linda Claret, Lei Feng, R Eric Davis, and Felipe Samaniego
Centre: MD Anderson Cancer Center


 




PosterSessionOnline
Logo Draft
 
Logo Cert